NewsMarkets

Health

Human Data Hints Psychedelics May Combat Inflammation

Researchers publish initial human data suggesting psilocybin reduces inflammation, potentially aiding patients with neurodegenerative diseases like Parkinson's.

2 publishers · 2 articles · first seen 21 Oct 2026 · updated 2h ago

Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made

The story so far

2 publishers have covered this in 2 articles since 21 Oct 2026. NPR Health published first, on 21 October at 15:33 UTC; MedPageToday.com - medical news for physicians followed 5h 27m later. The most recent article, from MedPageToday.com - medical news for physicians, appeared on 21 October at 21:00 UTC.

Outlets reporting it: NPR Health (major outlet), MedPageToday.com - medical news for physicians.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. New human data hints at psychedelics' potential to combat inflammation NPR Health ·
  2. Psilocybin Tied to Lower Inflammation in Parkinson's Trial MedPageToday.com - medical news for physicians
Embed this story

Paste this into any web page to show the live odds, with a link back here.